Lupus News Today Home | Lupus News Today
The Web's Daily Resource for Lupus News| Lupus News Today
The U.S. Food and Drug Administration (FDA) has approved Gazyva (obinutuzumab) as an add-on treatment for adults with lupus nephritis, a form of lupus marked by kidney damage. “The approval of Gazyva by the FDA marks an important step towards a potential new standard of care for lupus nephritis, one that could allow clinicians to […] The post FDA approves Gazyva as lupus nephritis treatment appeared first on Lupus News Today.| Lupus News Today – The Web's Daily Resource for Lupus News
Once you receive a diagnosis of lupus, it is difficult to avoid its chronic impact. The disease stays on your mind and affects your perceptions and decisions. You may not be in a flare or “suffering,” but you are often still experiencing multiple, full-body symptoms. When these symptoms are minimal, that is, a 6 on […] The post Discoveries in immune regulation are magical ‘ma’ toward lupus cure appeared first on Lupus News Today.| Lupus News Today – The Web's Daily Resource for Lupus News
A single infusion of the experimental cell therapy ADI-001 led to reductions in disease activity for seven lupus patients in a clinical trial, according to preliminary data announced by its developer Adicet Bio. No serious side effects reported. “These preliminary results reinforce our belief that ADI-001 has the potential to transform the treatment landscape for […] The post Cell therapy ADI-001 reduces disease activity in lupus patients appeared first on Lupus News Today.| Lupus News Today – The Web's Daily Resource for Lupus News
Protecting your energy is crucial in life with chronic illness, says columnist Marisa Zeppieri, so be sure to avoid things that drain you.| Lupus News Today
Columnist Candace Semien writes that living consists of weaving a web of people and circumstances, including the challenges of lupus.| Lupus News Today
Columnist Candace Semien offers the ways she's found to rebuild her life from the fragments left behind by the bulldozer of lupus.| Lupus News Today
The Lupus Research Alliance has awarded grants to seven projects in the U.S. and Europe that seek to advance disease knowledge and treatment.| Lupus News Today
No systemic lupus erythematosus patient receiving the CAR T-cell therapy infusion relapsed, all remained in remission for up to 17 months.| Lupus News Today
Inflammatory macrophages, particularly M1-like macrophages, may be cause of more severe pediatric lupus nephritis, study says.| Lupus News Today
NKT cell activators hold promise for potential systemic lupus erythematosus (SLE) treatment, preclinical data show.| Lupus News Today
RSLV-132 failed to lessen damage caused by skin lesions in SLE in a trial, but tended to ease symptoms in patients with more active disease.| Lupus News Today
The FDA has updated the prescribing label for Lupkynis to show that it continues to safely preserve kidney function for up to three years.| Lupus News Today
Columnist Marisa Zeppieri shares ways to get involved in advocacy, an activity of great importance in the lupus community.| Lupus News Today
A self-administered, under-the-skin injection version of AstraZeneca’s Saphnelo (anifrolumab-fnia) was effective for reducing disease severity in adults with systemic lupus erythematosus (SLE), according to results from an interim analysis of a Phase 3 clinical trial. “Today’s news takes us one step closer in making the clinically meaningful benefits of Saphnelo accessible for more patients with […] The post Trial testing under-the-skin Saphnelo in SLE hits main goal appeared first on...| Lupus News Today – The Web's Daily Resource for Lupus News
Columnist Candace Semien describes the sort of personal surveillance she wants in case she has a lupus flare or other emergency.| Lupus News Today
Antiphospholipid antibodies (phospholipid are fat molecules) were seen to increase the likelihood of heart disease or the like with SLE.| Lupus News Today
Last updated Feb. 1, 2023, by Marisa Wexler, MS Fact-checked by Patricia Silva, PhD Lupus is an autoimmune disease in which the immune system attacks the body's healthy tissue; consequently, the disease can affect many organs and cause a wide range of symptoms. While it is not known exactly what...| Lupus News Today
Living with lupus used to make columnist Candace Semien feel isolated and ashamed, but now she refuses to wear that "scarlet letter."| Lupus News Today
As months turn into years and years turn into decades of living with systemic lupus erythematosus, we begin to record what helps mitigate or temper symptoms before they turn into a full-blown flare. In fact, it often feels like we have an entire armamentarium of health strategies we rely on just to make it through […] The post The unseen coping strategies that are part of my lupus management appeared first on Lupus News Today.| Lupus News Today – The Web's Daily Resource for Lupus News
Professor Tianfu Wu is developing a spleen-specific drug delivery system to suppress lupus-causing immune cells and reduce side effects.| Lupus News Today
Being honest about lupus symptoms and challenges helps us be proactive and stay committed to our health, writes columnist Candace Semien.| Lupus News Today
The FDA has approved Benlysta in an autoinjector that can be used at home to treat lupus nephritis, a kidney complication, in children.| Lupus News Today
Columnist Candace Semien had to recently confront "the uglies" when a lupus flare started to cause noticeable signs and symptoms.| Lupus News Today
A CAR T-cell therapy cleared disease-causing autoantibodies from the bloodstream of eight SLE patients without compromising vaccine response.| Lupus News Today
Author archive page for Margarida Maia.| Lupus News Today
Columnist Candace Semien explains living with lupus by invoking the mysterious and powerful TARDIS, part of the "Doctor Who" television show.| Lupus News Today
While your journey may look different than others, you can still forge your own path with advocacy, columnist Marisa Zeppieri writes.| Lupus News Today
Looking for information about living with Lupus? Read this brief introduction into what living with the disease means, and how to cope with symptoms.| Lupus News Today
Antibodies targeting the TFAM protein could increase the risk of blood clotting complications in people with lupus, a study found.| Lupus News Today
Learn more about the symptoms of lupus, which can include skin issues, kidney and bladder inflammation, and problems with joints and muscles.| Lupus News Today
Lupus is a chronic disorder wherein the immune system attacks healthy tissue, which can affect virtually every part of the body.| Lupus News Today
Looking for information on how a lupus diagnosis is made by specialists? Read all about lupus diagnoses here.| Lupus News Today
May marks Lupus Awareness Month, and advocates will be joining together to bring attention to the disease to help "Make Lupus Visible."| Lupus News Today
The FDA has granted fast track status to ADI-001, Adicet Bio’s CAR T-cell therapy for treatment-resistant systemic lupus erythematosus (SLE).| Lupus News Today
Author archive page for Lindsey Shapiro.| Lupus News Today
The pain from lupus may be constant, columnist Candace Semien writes, but with gratitude and hope, suffering is optional.| Lupus News Today
Looking for information on lupus treatment? Get basic lupus treatment information here at Lupus News Today.| Lupus News Today
Category archive page for Columns.| Lupus News Today
The website from which you got to this page is protected by Cloudflare. Email addresses on that page have been hidden in order to keep them from being accessed by malicious bots. You must enable Javascript in your browser in order to decode the e-mail address.| lupusnewstoday.com
Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her...| Lupus News Today
Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health...| Lupus News Today
Scientist Akiko Iwasaki will receive award to investigate whether ancient viral DNA in our cells is a potential trigger for lupus.| Lupus News Today
Looking for information on how a lupus diagnosis is made by specialists? Read all about lupus diagnoses here.| Lupus News Today
Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology &...| Lupus News Today
Mary M. Chapman began her professional career at United Press International, running both print and broadcast desks. She then became a Michigan correspondent for what is now Bloomberg BNA, where she mainly covered the automotive industry plus legal, tax and regulatory issues. A member of the...| Lupus News Today
Most patients with systemic lupus erythematosus (SLE) experience joint pain, typically in the hands, wrists, and knees, a study found.| Lupus News Today
The first patient was dosed in the U.S. as part of a clinical trial testing of NK cell therapy candidate AlloNK for lupus nephritis.| Lupus News Today
Ampel BioSolutions is launching LuGENE, a lupus blood test that uses AI to look at gene activity to predict flares and personalize treatments.| Lupus News Today
FibroBiologics has filed an application with the U.S. Patent and Trademark Office covering the use of its technology to treat lupus.| Lupus News Today
The additional heat and light of spring can be dangerous with lupus. Here's how columnist Marisa Zeppieri navigates the change of seasons.| Lupus News Today
Lupus Therapeutics is teaming up with Artiva Biotherapeutics on a Phase 1 trial of AlloNK, a natural killer cell therapy for lupus nephritis.| Lupus News Today
Seattle Children's will start a clinical trial testing CAR T-cell therapy in children with lupus this summer after getting FDA clearance.| Lupus News Today
The LRA will give up to $600,000 to each of its seven Lupus Mechanisms and Targets Award recipients to develop better treatments for lupus.| Lupus News Today
AlloNK cells are collected from the umbilical cord blood of healthy donors and cryopreserved for immediate use in outpatient settings.| Lupus News Today
The first patient has been treated in a Phase 1 clinical trial testing CAR T-cell therapy CC-97540 in people with severe, refractory lupus.| Lupus News Today
Treatment with hydroxychloroquine does not appear to lower the risk of preeclampsia during pregnancy in women with lupus, a study reports.| Lupus News Today
DNA-bound proteins released from traps cast by neutrophils may predict who with lupus nephritis is most likely to respond to kidney treatment.| Lupus News Today
Researchers have identified proteins in the urine that could serve as biomarkers of kidney involvement in people with lupus.| Lupus News Today
When TLR7, a protein that normally triggers an immune response against viruses, builds up in immune cells, the immune system may cause lupus.| Lupus News Today
A three-year federal grant to the Lupus Foundation of America aims to support efforts to get more Black patients in lupus clinical trials.| Lupus News Today
